Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBM32B Inhibitors

RBM32B inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RBM32B, an RNA-binding protein that plays a role in the regulation of post-transcriptional gene expression. RBM32B, as part of the RNA-binding motif (RBM) family, is involved in key processes such as mRNA splicing, stability, and translation. The protein contains RNA recognition motifs (RRMs) that allow it to bind to specific RNA sequences, modulating the processing and maturation of mRNA. This regulation is critical for ensuring that mRNA transcripts are properly spliced and translated into proteins, which are essential for maintaining normal cellular functions. RBM32B inhibitors function by binding to important regions of the protein, such as its RNA-binding domain, thereby disrupting its ability to interact with RNA and carry out its regulatory functions. Inhibition of RBM32B can lead to significant changes in post-transcriptional gene expression, affecting the stability, splicing, and translation of various mRNA molecules. By blocking the RNA-binding activity of RBM32B, these inhibitors interfere with the normal processing of RNA transcripts, potentially leading to alterations in protein synthesis and the generation of different protein isoforms. Researchers use RBM32B inhibitors to investigate the specific role of this protein in regulating RNA metabolism and to explore how its inhibition impacts gene expression at the post-transcriptional level. These inhibitors provide valuable tools for studying the broader functions of RNA-binding proteins in cellular processes such as growth, differentiation, and response to external signals. Additionally, RBM32B inhibitors offer insights into the complex networks of RNA-protein interactions, helping to elucidate how cells regulate their proteome in response to changing physiological conditions. Through the study of RBM32B inhibitors, scientists gain a deeper understanding of the molecular mechanisms that govern RNA processing and its influence on cellular behavior.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Cyclin-dependent kinase inhibitor that can suppress transcription and potentially lower mRNA and protein levels.

Betulinic Acid

472-15-1sc-200132
sc-200132A
25 mg
100 mg
$117.00
$344.00
3
(1)

Inhibits topoisomerase and can induce DNA damage responses, potentially affecting transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Topoisomerase I inhibitor that could lead to reduced transcription and decreased protein expression.

Mitoxantrone

65271-80-9sc-207888
100 mg
$285.00
8
(1)

DNA intercalator and topoisomerase II inhibitor, which may inhibit transcription and reduce protein synthesis.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$145.00
$569.00
4
(1)

Intercalates with DNA and may inhibit transcription processes necessary for protein expression.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Inhibits DNA topoisomerase II, potentially affecting transcription and lowering expression of certain proteins.

Aclacinomycin A

57576-44-0sc-200160
5 mg
$132.00
10
(1)

Interferes with nucleic acid synthesis and can inhibit RNA polymerase, affecting mRNA and protein levels.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

Inhibits DNA polymerase and may impact mRNA synthesis and subsequent protein expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that can also affect DNA topoisomerase, potentially reducing transcription.